Invention Grant
- Patent Title: Crystalline anti-hTNFalpha antibodies
- Patent Title (中): 结晶抗hTNFalpha抗体
-
Application No.: US13225281Application Date: 2011-09-02
-
Publication No.: US08436149B2Publication Date: 2013-05-07
- Inventor: David W. Borhani , Wolfgang Fraunhofer , Hans-Juergen Krause , Anette Koenigsdorfer , Gerhard Winter , Stefan Gottschalk
- Applicant: David W. Borhani , Wolfgang Fraunhofer , Hans-Juergen Krause , Anette Koenigsdorfer , Gerhard Winter , Stefan Gottschalk
- Applicant Address: BM Hamilton
- Assignee: AbbVie Biotechnology Ltd
- Current Assignee: AbbVie Biotechnology Ltd
- Current Assignee Address: BM Hamilton
- Agency: McCarter & English, LLP
- Agent Cristin H. Cowles
- Main IPC: C07K16/00
- IPC: C07K16/00 ; G01N31/00
Abstract:
The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.
Public/Granted literature
- US20120251550A1 Crystalline anti-hTNFalpha antibodies Public/Granted day:2012-10-04
Information query
